Hitachi High-Tech releases HT7700 transmission electron microscope

NewsGuard 100/100 Score

Hitachi High-Technologies Corporation (TOKYO:8036)(Hitachi High-Tech) has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.

The HT7700 model, set for an August 2010 launch by Hitachi High-Tech, was developed as the latest addition to the H-7000 series of Hitachi TEM products, which have seen sales of over 800 units worldwide. The HT7700 was designed with groundbreaking features, chief among these are a superior level of operability and an extensive range of useful digital imaging functions. These features ensure usability across the broadest possible range of applications fields, from the main application area of biomedical to nanotechnology and soft carbon based materials. Furthermore, the decision to integrate a high resolution digital camera and microscope operation has made the system control simplified through the use of one monitor screen possible, which allows for sample observation even under ordinary room lighting.

Hitachi High-Tech is scheduled to have a working model of the HT7700 on display at the Microscopy & Microanalysis 2010 (M&M-2010), the annual meeting of the Microbeam Analysis Society being held in Portland, Oregon (USA) from August 1-5, 2010.

Source:

Hitachi High-Technologies Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants